Objective: To examine parents' and health professionals' views on informed choice in newborn blood spot screening, and assess information and communication needs.
Introduction:
Since the introduction of blood spot screening of all newborns for phenylketonuria (PKU) and congenital hypothyroidism (CHT) in the UK, in the 1960s and 1980s respectively, consent for screening has generally been assumed or implied. Usually, midwives looking after mothers and babies in their own homes during early postnatal visits, would gently forewarn mothers of the 'heel-prick' to collect a little of their babies' blood, portraying it as routine and no cause for concern. This was primarily because screening for PKU and CHT was known to be highly effective in preventing severe disability. More recently, however, this practice has been challenged by raised expectations for informed consent for treatment, screening, diagnosis and research. In comparison, the second report in 2002 promotes informed choice for screening, and calls for 1) screening to be offered to individuals who are helped to make an informed choice about it, and 2) screening to be seen as a programme to assist in the early identification of diseases and not a guarantee of diagnosis or cure. 4 This has led to the proliferation of written information for parents, some of which addresses the benefits and possible harms of screening so that parents can make an informed choice about whether or not their baby should be screened.
[Place box 1 about here]
Demands for choice, however, are in tension with concerns about child health and current newborn screening practice. 6 Questions arise about whether choice will lead to reduced uptake in screening; 7 what information people need and its effects on their decision-making; 8 and whether informed choice is appropriate for all screening programmes.
7
A parent refusing newborn screening for a very low prevalence condition with an unproven intervention would be more justified in making such a refusal than a parent refusing screening for a high prevalence, catastrophic condition which is easily preventable 5;9 Newborn blood spot screening presents a range of scenarios between these two extremes (see box 2), thereby raising tensions between parental autonomy and preventive public health strategies. This paper reports the findings that relate specifically to informed choice.
Methods

Sampling
Parents were purposively recruited for their diverse experiences of screening and the conditions, and socio-demographic status. Parents of unaffected children were sought through statutory services (a suburban GP surgery, an inner city statutory parent support group and a market town factory).
Parents of children found to be affected by the conditions were accessed through condition-specific support organisations. Most parents had a child under three years old, and many of these had babies under one year old.
Two parents attending one focus group had young adult children. Overall the ages of the children born to parents ranged from 6 weeks to 23 years.
Health professionals were recruited through professional and service organisations, screening training events and a charity. 
Interviews and focus groups
Recruitment
Participation in the research was voluntary, anonymous and confidential.
Study information was distributed through contacts in health service and parent organisations, or sent directly to parents who responded to advertisements placed in condition-specific support organisation newsletters. Those who wished to participate were first asked to complete, sign and submit two consent forms, which were then signed by a researcher and one returned to the participant.
Data collection and Analysis
Semi-structured interview guides were developed for the different categories of parents. Topics included: experience of the heel-prick test and the screening process overall including receiving results; the timing and format of information they received about the test; who provided the information; what, in retrospect, they would have liked to have known before the test; and issues related to informed choice and consent. In focus groups, parents were shown copies of leaflets about newborn screening, and asked for feedback on the information provided. Health professionals were asked about their role in the newborn blood spot programme, particularly in communicating with parents and delivering results, use of and access to useful information resources, views on informed choice and consent, issues and challenges in communicating with parents about newborn screening, and training needs.
The guides were piloted in initial focus groups and interviews and adapted to capture both the similar and divergent issues across the different categories of interviewee. All interviews and focus groups were taperecorded and transcribed. Two researchers analysed each transcript, identified themes, coded the transcripts and compared similarities and differences until data saturation was achieved.
Results
Analysis of the data revealed debates about a spectrum of circumstances relating to the degree of parental choice and methods for recording parents' decisions (see Figure 1 ). This spectrum ranges from no parental choice Even with minimal information, most parents reported that they were happy to accept what they perceived as routine screening recommended by their midwife and the health service. Focusing on other priorities postnatally, parents paid little attention to the test and were unfamiliar with the conditions being screened. A mother said:
All I really remember about that was being told that if anything comes up positive, it can be treated easily. I can't remember [anything about the conditions]. … it's only 6 days after the birth, your head is all over the place, so I took very little notice of it. I hadn't had much sleep either. So I probably didn't listen to what she was saying if I'm truthful…and I remember actually thinking 'oh that'll be fine, that'll be okay' [CHT mother].
Other parents had received a leaflet as well as information orally from the midwife, and had discussed screening with the midwife.
I was given a leaflet on the day, [and] Several parents, particularly those whose babies were later found to have one of the conditions, said they did not recall midwives drawing attention to the significance of the tests. Most parents of unaffected children heard nothing more after the blood sample was taken having been told that 'no news is good news'.
I knew something was going to happen because of the pre-baby lessons you go to. That wasn't very informative. They just said they'd do this test. They never said why it was being taken…what information you'd get. And then when the baby was tested you just got absolutely nothing, nothing at all [Unaffected mother].
With hindsight, most parents see no need for detailed information about the screening tests or the conditions tested for before, or at the time of, the test. Prior, basic knowledge about the conditions and their implications was regarded as most significant when babies were found to have the conditions.
You need to know basics really…I think it's good to know what the test is and
Having got the letter back saying it's fine, I'm not so bothered about the written information, but if there was a problem I'd be furious if I hadn't known earlier about the conditions [Unaffected mother].
You need to know from the beginning…what these initials stand for… I didn't know what PKU was… I didn't know what the consequences were. It would have been nice to know why the baby was having the heel prick and what these initials stood for [PKU mother].
Degree of Parental Choice
Most parents did not experience newborn screening as something they could choose or refuse on behalf of their baby; most perceived it as a routine test. [screening] If they had been offered a choice, many said they would have opted for their child to be screened.
I'm very much in favour of
I just assumed it must be important to do it. So, I just thought that's fine. If it'd been an injection I suppose you'd give it more thought. If it's a screening thing then that can only be good can't it? [Unaffected parent]
The strength of feeling favouring screening was strongest amongst parents of affected babies, most of whom considered that screening should be compulsory or at least routine. Whilst most parents said they were unlikely to opt out of screening or parts of screening, one parent of an unaffected child did indicate that she might choose to opt out of screening for some of the conditions, particularly if there was some controversy over the value of screening for that condition.
Recording parents' decisions
Many parents said they did not recall giving consent for the heel-prick test.
It wasn't anything I consented to. I don't remember signing or agreeing [Unaffected mother].
Others recalled being given information orally by the midwife and giving verbal consent. There was some support for implied or verbal consent from parents and some health professionals, mostly from those who believed that screening should be routine.
…if the mother can't stand it and has to go out while the grandmother [holds the baby], then…they ought to have written consent then, but obviously if it's you actually holding the baby then that's implied consent anyway, if you're holding the baby's heel up [CF mother/GP]. I think a verbal discussion really between midwife and mother or mother and father to say, 'we do this test and it's for so and so, have you any objections to us doing it?' And I think that's enough really. I mean you don't have to give written consent to have your inoculations or anything like that, do you? [PKU mother]
Some health professionals preferred a verbal consent model, but believed that in the current increasingly litigious climate, written consent might offer them greater legal protection. *
Well, legally, verbal consent isn't really satisfactory. If anything happens, say if the baby got an infected foot or the test wasn't done correctly, you know, verbal consent means very little really. A midwife's… word against the parent. … Maybe they could have just a space there, consent for the test. It might be easier, without creating any more paperwork [Health Visitor].
When asked for feedback on a proposed model of verbal consent and written dissent, many health professionals and parents of affected children were in favour because it would make it easier for parents to give rather than withhold their consent. Some health professionals, however, argued that consent and dissent should be treated in the same way; otherwise it might appear coercive. They also thought a small minority of parents would refuse to sign for dissent. Other parents raised the issue of the need for written consent if blood spots are to be stored.
…..if they're keeping the blood I think we ought to sign [Unaffected parent]. I mean I don't think anybody would have been too bothered with the verbal consent until they found out it's going to be stored for however long, then they sort of think 'hold on' [Unaffected parent].
Some health professionals also preferred both written consent and dissent because they believed it would protect them better legally, and provide a better record for the future as to whether or not screening had taken place.
[Consent] should be in writing and I also think that if they opt out from anything it must be in writing that they have opted out, because we had a situation where a child hasn't been tested for cystic fibrosis, but the parents were under the impression that they had been tested… It was a boundary problem …so we had been told by the parents that she had been screened and it was negative, when in fact she hadn't been screened and when investigated it was positive [CF nurse]. In summary, parents' and midwives' experienced screening that was virtually compulsory with little information and assumed consent. They supported improved information and communication for parental choice, albeit tempered by concerns about children's health.
Discussion
This research has shown that parents and health professionals recognise a tension between informed choice and children's health in the context of newborn blood spot screening. Some participants propose resolving this tension with better information and communication, and some with rigorous dissent procedures to mitigate the possibility of refusals.
Although this study includes the views of a small number of parents and health professionals who have had experience of newborn blood spot screening, its strength lies in its purposive sampling, which enabled us to elicit the range of views of diverse groups of parents and health professionals from a variety of geographic areas in the UK, and with a wide range of experiences and roles in newborn screening.
While every effort was made to include a variety of parents with differing perspectives and experiences of screening, and from differing sociodemographic backgrounds, the participants to some extent were selfselected in that they responded to advertisements or invitations to participate in the study and therefore had some degree of interest in the topic. The context of one-to-one interviewing with parents of affected children and focus group discussions primarily with parents of unaffected children may cause some discrepancy in the type and depth of information received from these parents. Some parents in focus groups, whose children were unaffected by any of the conditions, expressed limited views on screening.
This may be because it is difficult to elicit people's views on a topic that has little impact on their lives, or because their babies, who were with mothers in two focus groups, distracted them. Showing parents of unaffected babies copies of leaflets was an effective way of eliciting views from them about the type of information they would have liked to have seen in a leaflet on newborn screening, but we did not elicit this type of feedback from parents in the context of one-to-one telephone interviews.
The findings of this study have been presented to mixed working groups of health professionals and parents who have responded favourably to the content, and drawn on it in the formulation of policies to support informed choice for newborn screening.
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Other research supports our finding that parents generally report receiving little information about screening, and are not aware that they have any choice. • to accept or decline screening for all or some of the conditions;
• to accept or decline tests that identify carrier status;
• to accept or decline follow-up screening or diagnostic tests;
• to accept or decline receiving invitations to participate in research related to the newborn blood spot screening programme.
• The extent of parent choice to be offered with regard to the use of DNA analysis as part of screening, and the use of residual blood spots for wider public health purposes and research remain limited.
Box 2: Context of informed choice for newborn blood spot screening
Approximately 600,000 babies each year, tested for serious but rare conditions:
• Eleven babies in every 100,000 births will have phenylketonuria (PKU), 21 a condition which affects the processing of a protein called phenylalanine, that, unless treated, can lead to serious developmental problems and mental disability by the time the child is six months old.
• One in approximately every 4,000 babies in the UK will have congenital hypothyroidism (CHT), 22 caused by a malfunctioning or missing thyroid gland. Babies with CHT lack the hormone thyroxine, needed for normal growth and development, and can become severely mentally impaired.
• One in every 2,500 babies has cystic fibrosis (CF), 23 a condition that affects the lungs and digestive systems, leading to chronic illness.
• One in 2,380 babies in the UK is born with a sickle cell disorder (SCD), 24 which causes the red blood cells to change to a crescent shape and become stuck in small blood vessels, causing pain, tissue damage and infection that can be fatal. primarily as a parent, but commented briefly on her views as a health professional. Another mother was formerly a midwife and commented in a focus group on her previous experiences as a midwife. ** One parent was also a GP and was interviewed separately as a parent and as a health professional. 
